QA: Repare Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001808158_2023_Repare_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001808158, Repare Therapeutics Inc.

  xvar xval
0 AssetsCurrent 353,979,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,228,000
3 remainder_Assets 5,868,000
4 LiabilitiesCurrent 78,619,000
5 LiabilitiesNoncurrent 5,939,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 32,560,000
9 ResearchAndDevelopmentExpense 119,066,000
10 remainder_Expenses 15,147,000
11 remainder_Revenues 0
12 remainder_NetIncome 137,726,000
13 remainder_ComprehensiveNetIncome -428,000
  yvar yval
0 Assets 364,075,000
1 Liabilities 84,558,000
2 Expenses 166,773,000
3 Revenues 0
4 StockholdersEquity 279,517,000
5 NetIncome -29,047,000
6 ComprehensiveNetIncome -29,261,000
7 BaseVar 376,780,000
8 EconomicCapitalRatio 2.01

Edgar->Model Mapping

Feature Distribution

Change over Time